Data-driven prioritization and preclinical evaluation of therapeutic targets in glioblastoma.
Neuro-oncology advances(2020)
摘要
The MAPK9 inhibitor RGB-286638 showed promising in vitro results. Furthermore, in vivo target engagement studies and combination therapies with this compound warrant further exploration.
更多查看译文
关键词
MAPK9,RRM2,XIAP,glioblastoma,therapeutic targets
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要